Skip to main navigation

Prime Medicine Logo

Overview
News & Events
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Corporate Governance
Sec filings
IR Resources

Press Releases

Year

November 8, 2023

Prime Medicine to Present at Upcoming Investor Conferences

November 3, 2023

Prime Medicine Reports Third Quarter 2023 Financial Results and Provides Business Updates

October 27, 2023

Prime Medicine Presents First-ever Prime Editing Data in Non-human Primates Demonstrating Highly Efficient Ability of Prime Editors to Precisely Correct Disease-causing Mutation of GSD1b

October 24, 2023

Prime Medicine Presents First In Vivo Proof-of-Concept Prime Editing Data Demonstrating Ability of Prime Editors to Treat Ophthalmological Diseases

October 17, 2023

Prime Medicine to Highlight Positive Preclinical Developments Across Prime Editing Pipeline and Platform at Upcoming Industry Conferences

September 19, 2023

Prime Medicine to Present at Upcoming Investor Conferences

August 31, 2023

Prime Medicine to Present at Upcoming Investor Conferences

August 7, 2023

Prime Medicine Reports Second Quarter 2023 Financial Results and Provides Business Updates

June 22, 2023

Prime Medicine and Cimeio Therapeutics Announce Research Collaboration to Develop Prime Edited Shielded-Cell & Immunotherapy Pairs™ for Genetic Diseases, Acute Myeloid Leukemia and Myelodysplastic Syndrome

May 31, 2023

Prime Medicine to Present at Investor Conferences in June

Pagination

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 18

Print Page

Email Alerts

RSS Feeds

Contact IR

prime_

Site - Footer Bottom

Contact Us
Privacy Policy
Terms of Use

© 2021-2023 Prime Medicine, Inc. All rights reserved. PRIME MEDICINE and the Prime Medicine logos are trademarks of Prime Medicine, Inc.